Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-05
2011-04-05
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07919491
ABSTRACT:
A pyridine derivative novel compounds of formula (I) or a pharmaceuticallyacceptable salt thereof where all variables are defined herein. The compounds are useful in the treatment of psychotic disorders.
REFERENCES:
patent: 2005/0090533 (2005-04-01), Hoffmann
patent: 1035115 (2000-09-01), None
patent: 03/066621 (2003-08-01), None
patent: 03/066635 (2003-08-01), None
patent: 2005/002577 (2005-01-01), None
Natsugari, H. et al.; Novel, Potent and orally active substance P Antagonists: Synthesis and Antagonist Activity of N-Benzylcarboxamide Derivatives of Pyrido [3,4-b] pyridine; Journal of Medicinal Chemistry; 1995; 38; 3106-3120; American Chemical Society.
Ikeura, Y., et al.; Potent NK1 Receptor Antagonists: Synthesis and Antagonistic Activity of various Heterocycles with anN-[3,5-Bis(trifluoremethyl)benzyl]-N-methylcarbamoyl Substituent; Chem. Pharm. Bull.; 1997; 45/10; 1642-1652; Pharmaceutical Society of Japan.
Alvaro Giuseppe
Belvedere Sandro
GlaxoSmithKline LLC
Habte Kahsay T
Young J. Scott
LandOfFree
Pyridine derivatives and their use in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives and their use in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives and their use in the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2669483